Protolabs Reports Financial Results for the Second Quarter of 2021 - Proto Labs (NYSE:PRLB)

Record Revenue of $123.0 million in the Second Quarter of 2021, an increase of 15% over the Second Quarter of 2020

Proto Labs, Inc. PRLB, the world's largest ecommerce manufacturer and supplier of on-demand prototype and production parts, today announced financial results for the second quarter ended June 30, 2021.

Second Quarter 2021 Highlights include:

Revenue for the second quarter of 2021 was $123.0 million, representing a 15.5 percent increase compared to revenue of $106.6 million in the second quarter of 2020.
Hubs generated $8.9 million of revenue in the second quarter, representing growth of 45.6 percent over the second quarter of 2020.
Net income for the second quarter of 2021 was $12.9 million, or $0.47 per diluted share.
Non-GAAP net income was $10.7 million, or $0.39 per diluted share. See "Non-GAAP Financial Measures" below.

"During the second quarter of 2021, we experienced strong demand, and delivered record revenues despite the challenges of labor availability in the US. We are emerging from the pandemic stronger than ever in the custom parts space," said Rob Bodor, President and Chief Executive Officer. "I want to thank the employees of Protolabs for all that they did in the quarter, and we are confident that the best is yet to come."

Additional Second Quarter 2021 Highlights include:

Protolabs served 23,253 unique product developers during the quarter, representing a 36.5 percent increase over the second quarter of 2020.
Gross margin in the second quarter of 2021 was 46.0 percent of revenue; Non-GAAP gross margin was 46.8 percent of revenue. See "Non-GAAP Financial Measures" below.
EBITDA margin was 21.3 percent of revenue in the second quarter of 2021; adjusted EBITDA margin was 18.8 percent of revenue in the second quarter of 2021. See "Non-GAAP Financial Measures" below.
Cash and investments balance was $89.0 million as of June 30, 2021.

"The environment is ripe for growth and our digital manufacturing model is leading the way," added John Way, Chief Financial Officer. "Our profitable business model drives a healthy balance sheet with $89 million in cash and investments and no debt, giving us the flexibility to continue to invest in future growth and lead the digital custom parts space."

Non-GAAP Financial Measures

The company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates and revenue earned from our acquisition of Hubs (collectively, "non-GAAP revenue growth"). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

The company has included earnings before interest, taxes, depreciation and amortization ("EBITDA") and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, "Adjusted EBITDA"), in this press release to provide investors with additional information regarding the company's financial results.

The company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, and transaction costs (collectively, "non-GAAP operating margin"), in this press release to provide investors with additional information regarding the company's financial results.

The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, "non-GAAP net income"), in this press release to provide investors with additional information regarding the company's financial results.

The company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP operating margin, non-GAAP revenue growth and Adjusted EBITDA, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company's management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company's business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

Conference Call

The company has scheduled a conference call to discuss its second quarter 2021 financial results and third quarter 2021 outlook today, July 29, 2021 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/4ugs54z8. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

About Protolabs

Protolabs is the world's leading digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom components in as fast as 1 day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces manufacturing costs, and enables supply chain agility throughout the product life cycle. Visit protolabs.com for more information.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical or current facts are "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the "Risk Factors" section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs' future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)


		June 30,		December 31,
			2021		2020
		(Unaudited)
Assets
Current assets
Cash and cash equivalents		$	41,909	$	127,603
Short-term marketable securities			18,341		34,088
Accounts receivable, net			83,470		57,877
Inventory			9,111		10,862
Income taxes receivable			4,575		540
Prepaid expenses and other current assets			10,107		11,032
	Total current assets		167,513		242,002

Property and equipment, net			288,495		282,666
Goodwill			407,191		128,752
Other intangible assets, net			41,674		14,350
Long-term marketable securities			28,700		59,357
Operating lease assets			8,801		9,855
Finance lease assets			2,147		2,396
Other long-term assets			4,769		4,826
	Total assets	$	949,290	$	744,204

Liabilities and shareholders' equity
Current liabilities
Accounts payable		$	26,038	$	18,248
Accrued compensation			14,930		11,989
Accrued liabilities and other			15,072		16,193
Current contingent consideration			2,936		-
Current operating lease liabilities			2,847		3,272
Current finance lease liabilities			554		552
Income taxes payable			40		-
	Total current liabilities		62,417		50,254

Long-term contingent consideration			2,693		-
Long-term operating lease liabilities			7,097		7,586
Long-term finance lease liabilities			1,639		1,919
Long-term deferred tax liabilities			36,898		33,854
Other long-term liabilities			6,569		6,235

Shareholders' equity			831,977		644,356
Total liabilities and shareholders' equity		$	949,290	$	744,204



Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)

	Three Months Ended				Six Months Ended
	June 30,				June 30,
		2021		2020		2021			2020
Revenue
Injection Molding	$	58,168	$	57,894	$	114,527		$	112,670
CNC Machining		41,592		28,760		78,295			66,645
3D Printing		18,170		14,236		35,405			30,184
Sheet Metal		4,717		4,669		9,936			10,318
Other		401		1,016		1,011			1,866
Total revenue		123,048		106,575		239,174			221,683

Cost of revenue		66,423		54,119		127,219			111,127
Gross profit		56,625		52,456		111,955			110,556

Operating expenses
Marketing and sales		21,044		16,936		40,524			35,116
Research and development		11,060		8,648		23,241			17,635
General and administrative		8,417		12,521		27,825			26,629
Total operating expenses		40,521		38,105		91,590			79,380
Income from operations		16,104		14,351		20,365			31,176
Other income (loss), net		137		767		(176	)		1,821
Income before income taxes		16,241		15,118		20,189			32,997
Provision for income taxes		3,326		2,511		3,562			6,406
Net income	$	12,915	$	12,607	$	16,627		$	26,591

Net income per share:
Basic	$	0.47	$	0.47	$	0.60		$	1.00
Diluted	$	0.47	$	0.47	$	0.60		$	0.99

Shares used to compute net income per share:
Basic		27,735,732		26,660,498		27,600,684			26,718,652
Diluted		27,744,870		26,760,866		27,741,464			26,837,938


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

	Six Months Ended
	June 30,
		2021			2020
Operating activities
Net income	$	16,627		$	26,591
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		20,127			15,855
Stock-based compensation expense		10,561			6,672
Deferred taxes		419			5,651
Amortization of marketable securities		261			129
Realized gain on available-for-sale securities		(117	)		-
Other		125			(854	)
Changes in operating assets and liabilities		(19,511	)		(627	)
Changes in fair value of contingent consideration		(7,763	)		-
Net cash provided by operating activities		20,729			53,417

Investing activities
Purchases of property, equipment and other capital assets		(23,929	)		(33,305	)
Cash used for acquisitions, net of cash acquired		(127,413	)		-
Purchases of other assets and investments		-			(3,000	)
Purchases of marketable securities		(15,159	)		(57,212	)
Proceeds from sales of marketable securities		47,694			-
Proceeds from maturities of marketable securities		13,725			28,225
Net cash used in investing activities		(105,082	)		(65,292	)

Financing activities
Proceeds from exercises of stock options and other		3,838			2,855
Purchases of shares withheld for tax obligations		(4,209	)		(3,367	)
Repurchases of common stock		(1,210	)		(14,686	)
Principal repayments of finance lease obligations		(275	)		-
Net cash used in financing activities		(1,856	)		(15,198	)
Effect of exchange rate changes on cash and cash equivalents		515			(149	)
Net decrease in cash and cash equivalents		(85,694	)		(27,222	)
Cash and cash equivalents, beginning of period		127,603			125,225
Cash and cash equivalents, end of period	$	41,909		$	98,003



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
		2021			2020			2021			2020
Non-GAAP net income, adjusted for stock-based compensation expense,
amortization expense, unrealized (gain) loss on foreign currency and
transaction costs
GAAP net income	$	12,915		$	12,607		$	16,627		$	26,591
Add back:
Stock-based compensation expense		4,941			3,639			10,561			6,672
Amortization expense		1,490			754			3,033			1,508
Unrealized (gain) loss on foreign currency		(402	)		(139	)		220			(936	)
Transaction costs ¹		(7,655	)		-			(5,140	)		-
Total adjustments ²		(1,626	)		4,254			8,674			7,244
Income tax benefits on adjustments ³		(575	)		(987	)		(3,576	)		(1,662	)
Non-GAAP net income	$	10,714		$	15,874		$	21,725		$	32,173

Non-GAAP net income per share:
Basic	$	0.39		$	0.60		$	0.79		$	1.20
Diluted	$	0.39		$	0.59		$	0.78		$	1.20

Shares used to compute non-GAAP net income per share:
Basic		27,735,732			26,660,498			27,600,684			26,718,652
Diluted		27,744,870			26,760,866			27,741,464			26,837,938


¹Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.
²Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and transaction costs were included in the following GAAP consolidated statement of operations categories:
	Three Months Ended						Six Months Ended
	June 30,						June 30,
		2021			2020			2021			2020
Cost of revenue	$	1,011		$	936		$	1,988		$	1,799

Marketing and sales		929			750			1,782			1,368
Research and development		744			607			1,368			1,128
General and administrative		(3,908	)		2,100			3,316			3,885
Total operating expenses		(2,235	)		3,457			6,466			6,381

Other (income) loss, net		(402	)		(139	)		220			(936	)
Total adjustments	$	(1,626	)	$	4,254		$	8,674		$	7,244

³For the three and six-month periods ended June 30, 2021 and 2020, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2021			2020			2021			2020
Revenue	$	123,048		$	106,575		$	239,174		$	221,683
Income from operations		16,104			14,351			20,365			31,176
GAAP operating margin		13.1	%		13.5	%		8.5	%		14.1	%
Add back:
Stock-based compensation expense		4,941			3,639			10,561			6,672
Amortization expense		1,490			754			3,033			1,508
Transaction costs¹		(7,655	)		-			(5,140	)		-
Total adjustments		(1,224	)		4,393			8,454			8,180
Non-GAAP income from operations	$	14,880		$	18,744		$	28,819		$	39,356
Non-GAAP operating margin		12.1	%		17.6	%		12.0	%		17.8	%


¹Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.



Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2021			2020			2021			2020
GAAP net income	$	12,915		$	12,607		$	16,627		$	26,591
Amortization expense		1,490			754			3,033			1,508
Depreciation expense		8,578			7,143			17,094			14,347
Interest income, net		(65	)		(368	)		(152	)		(928	)
Tax expense		3,326			2,511			3,562			6,406
EBITDA		26,244			22,647			40,164			47,924
Add back:
Stock-based compensation expense		4,941			3,639			10,561			6,672
Unrealized (gain) loss on foreign currency		(402	)		(139	)		220			(936	)
Transaction costs¹		(7,655	)		-			(5,140	)		-
Total adjustments		(3,116	)		3,500			5,641			5,736
Adjusted EBITDA	$	23,128		$	26,147		$	45,805		$	53,660


¹Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth
(In thousands)
(Unaudited)

	Three Months Ended June 30, 2021										Three Months Ended June 30, 2020		%
	GAAP		Foreign Currency¹			Hubs Acquisition²			Non-GAAP		GAAP		Change³		% Change Organic⁴
Revenues
United States	$	95,344	$	-		$	(4,626	)	$	90,718	$	86,823	9.8	%	4.5	%
Europe		24,655		(1,913	)		(4,314	)		18,428		16,729	47.4		10.2
Japan		3,049		54			-			3,103		3,023	0.9		2.6
Total Revenue	$	123,048	$	(1,859	)	$	(8,940	)	$	112,249	$	106,575	15.5	%	5.3	%


	Six Months Ended June 30, 2021										Six Months Ended June 30, 2020		%
	GAAP		Foreign Currency¹			Hubs Acquisition²			Non-GAAP		GAAP		Change³		% Change Organic⁴
Revenues
United States	$	186,397	$	-		$	(7,783	)	$	178,614	$	176,899	5.4	%	1.0	%
Europe		46,104		(3,473	)		(6,920	)		35,711		37,516	22.9		(4.8	)
Japan		6,673		(31	)		-			6,642		7,268	(8.2	)	(8.6	)
Total Revenue	$	239,174	$	(3,504	)	$	(14,703	)	$	220,967	$	221,683	7.9	%	(0.3	)%

¹ Revenue for the three and six-month periods ended June 30, 2021 has been recalculated using 2020 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
²Revenue for the three and six-month periods ended June 30, 2021 has been recalculated to exclude revenue earned from our acquisition of Hubs, Inc. to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions.
³This column presents the percentage change from GAAP revenue for the three and six-month periods ended June 30, 2020 to GAAP revenue for the three and six-month periods ended June 30, 2021.
4 This column presents the percentage change from GAAP revenue for the three and six-month periods ended June 30, 2020 to non-GAAP revenue for the three and six-month periods ended June 30, 2021 (as recalculated using the foreign currency exchange rates in effect during the three- and six-month periods ended June 30, 2020, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.

Proto Labs, Inc.
Product Developer Information
(Unaudited)

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2021	2020	2021	2020
Unique product developers and engineers served	23,253	17,037	37,501	29,703

View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005120/en/

Market News and Data brought to you by Benzinga APIs